TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

TAK
Closed
$16.55
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 47,455 full-time employees. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Country

JP

CEO

Mr. Christophe Weber

IPO date

1949

Employees

47,455

ISIN

JP3463000004

Key stats

Open

$16.60

Volume

2.39M

Market cap

$53.42B

Prev. close

$16.61

Impl / hst vl

-

Open interest

$0.00

$16.51

Day’s Range

$16.62

$14.84

52W Range

$18.90

Valuation

44
Valuation score
Fairly Valued
P/E
45.06
P/S
1.92
P/B
1.11
Current ratio
1.27
Debt / Equity
0.55
ROE
2.61%
Gross margin
62.93%
Income growth
-123.46%
FCF growth
-92.68

Dec

1

Dividends

The next payment date will be Dec 1, 2026

Div. per Share

$0.63

Div. Yield

614.09%

Payout Ratio

-

Div. Growth YoY

0.01%

Analysts estimates

Consensus rating
Buy

The average rating from top 8 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$19.50
The top 16 analysts forecasts that 12-month price may increase by 17.83%, with a low of $16.21 and a high of $25.61
$16.21
Low
$19.50
Avg
$25.61
High
Current price

Earnings

Q1 ‘26 revenue
$6.77B
Q1 ‘26 net income
-$150.33M
Revenue
Net income
Previous EPS
-$0.05
Estimate EPS
$0.21
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply